TAROZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.635
AS - Asia 6.321
EU - Europa 5.366
AF - Africa 412
SA - Sud America 355
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.111
Nazione #
US - Stati Uniti d'America 6.500
CN - Cina 1.731
IT - Italia 1.731
SG - Singapore 1.599
VN - Vietnam 1.522
GB - Regno Unito 929
DE - Germania 573
SE - Svezia 538
HK - Hong Kong 392
IN - India 297
FR - Francia 270
BR - Brasile 258
UA - Ucraina 241
RU - Federazione Russa 209
NL - Olanda 190
BD - Bangladesh 183
KR - Corea 171
IE - Irlanda 168
JP - Giappone 113
TG - Togo 104
FI - Finlandia 99
CI - Costa d'Avorio 90
ZA - Sudafrica 84
BG - Bulgaria 73
CA - Canada 71
SC - Seychelles 68
EE - Estonia 61
AR - Argentina 47
TW - Taiwan 47
ID - Indonesia 44
ES - Italia 41
MX - Messico 39
PH - Filippine 38
BE - Belgio 36
CH - Svizzera 36
NG - Nigeria 32
TR - Turchia 29
GR - Grecia 28
HR - Croazia 27
AT - Austria 26
IQ - Iraq 21
TH - Thailandia 21
JO - Giordania 20
PL - Polonia 20
PK - Pakistan 19
AU - Australia 14
CZ - Repubblica Ceca 14
IR - Iran 14
PT - Portogallo 13
MY - Malesia 11
CL - Cile 10
EC - Ecuador 10
EG - Egitto 10
RO - Romania 10
UZ - Uzbekistan 9
VE - Venezuela 9
DK - Danimarca 8
LB - Libano 8
JM - Giamaica 7
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DZ - Algeria 5
HN - Honduras 5
KE - Kenya 5
KZ - Kazakistan 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MA - Marocco 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
SM - San Marino 4
AL - Albania 3
SN - Senegal 3
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EU - Europa 1
GH - Ghana 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 19.098
Città #
Singapore 1.081
Southend 775
Ashburn 632
Bologna 526
Fairfield 489
Chandler 413
Santa Clara 410
Hefei 383
Hong Kong 368
San Jose 360
Ho Chi Minh City 343
Houston 307
Hanoi 286
Wilmington 254
Woodbridge 252
Seattle 229
Ann Arbor 212
Beijing 203
Dong Ket 198
Princeton 187
Cambridge 186
Council Bluffs 173
Jacksonville 168
Dublin 162
Seoul 143
Boardman 139
New York 114
Los Angeles 112
Lomé 104
Lauterbourg 97
Abidjan 90
Milan 86
Nanjing 84
Tokyo 83
Helsinki 75
Westminster 73
Sofia 72
Dallas 71
Buffalo 69
Berlin 66
Padova 66
Redmond 64
Turin 58
Shenyang 56
San Diego 50
Da Nang 47
Rimini 47
Guangzhou 41
Bengaluru 40
Jinan 40
Munich 39
Saint Petersburg 39
Rome 38
Bremen 37
Haiphong 36
Brussels 33
Changsha 32
Frankfurt am Main 32
San Giorgio di Piano 32
Jakarta 31
Redwood City 31
Redondo Beach 30
São Paulo 30
Abeokuta 29
Medford 29
Cesena 28
Johannesburg 28
Chicago 25
Hebei 25
Hyderabad 25
Phoenix 25
Tianjin 25
Mülheim 24
Nuremberg 24
Shanghai 24
Bern 23
Des Moines 23
Hải Dương 23
Nanchang 23
Biên Hòa 22
Hangzhou 22
Zhengzhou 22
Toronto 21
Amman 20
Forlì 20
Mahé 19
Montreal 19
Amsterdam 18
Dearborn 18
Naples 18
Portogruaro 18
Falls Church 17
Jiaxing 17
Verona 17
Modena 16
Orem 16
Bari 15
Falkenstein 15
Florence 15
Lappeenranta 15
Totale 11.807
Nome #
Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease 370
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 340
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease 339
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 312
Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives 297
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 294
Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease 290
P-glycoprotein (ABCB1) and oxidative stress: Focus on Alzheimer's disease 287
Benzofuran-Based Hybrid Compounds for the Inhibition of Cholinesterase Activity, Abeta Amyloid Aggregation, and Abeta Neurotoxicity 285
Heat stress as a potential risk factor for vitamin D deficiency 249
Circulating Cell-Free DNA in Physical Activities 245
PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION 237
Antioxidant and Neuroprotective Effects of Fucoxanthin and Its Metabolite Fucoxanthinol: A Comparative In Vitro Study 226
Early effects of Aβ1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways 223
Rational Approach to discover multipotent anti-Alzheimer drugs 219
Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases 215
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 215
PQM130, a novel feruloyl-donepezil hybrid compound, effectively ameliorates the cognitive impairments and pathology in a mouse model of Alzheimer's disease 213
Antioxidant effectiveness of organically and non organically grown red oranges in cell culture systems 212
Neuroprotective effect of caffeic acid phenethyl ester in a mouse model of alzheimer's disease involves Nrf2/HO-1 pathway 212
Protective effects of cyanidin-3-O-beta-glucopyranoside against UVA-induced oxidative stress in human keratinocytes. 211
Meta-analysis of Parkinson's disease transcriptome data using TRAM software: Whole substantia nigra tissue and single dopamine neuron differential gene expression 211
Protective effects of 6-(Methylsulfinyl)hexyl isothiocyanate on Aβ1-42-induced cognitive deficit, oxidative stress, inflammation, and apoptosis in mice 210
Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson's Disease Data 210
Targeting the multifaceted neurotoxicity of Alzheimer's disease by tailored functionalisation of the curcumin scaffold 208
Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents. 208
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents 208
The Keap1/Nrf2-ARE pathway as a pharmacological target for chalcones 202
Associazione tra un isotiocianato e levodopa per il trattamento della malattia di Parkinson 201
Naturally inspired molecules as multifunctional agents for Alzheimer's disease treatment 199
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity 194
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease 191
Cold-storage affects antioxidant properties of apples in Caco-2 cells. 190
Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer's disease 190
Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in SH-SY5Y Cells 188
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 187
Bioattività di fragole (Fragaria ananassa) da coltivazione biodinamica e convenzionale. 187
Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors 183
Effetti della cianidina-3-O-beta-glucopiranoside sul danno cellulare indotto dai raggi UVA in cheratinociti in coltura. 182
Antioxidant and Anti-Melanogenesis Effects of Teucrium chamaedrys L. Cell Suspension Extract and Its Main Phenylethanoid Glycoside in B16-F10 Cells 180
Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease. 180
Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson’s disease 179
META-ANALYSIS OF SUBSTANTIA NIGRA TRANSCRIPTOME DATA: SEARCHING FOR NEW BIOMARKERS OF PD 179
Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates 179
Relevance of apple consumption for protection against oxidative damage induced by hydrogen peroxide in human lymphocytes. 178
Chrysin bonded to β-d-glucose tetraacetate enhances its protective effects against the neurotoxicity induced by aluminum in Swiss mice 175
Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. 175
Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomer-induced toxicity. 175
Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer’s disease 174
From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease 174
Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases 174
Potenziale azione protettiva e antiossidante delle mele nei confronti del danno genetico indotto dal perossido di idrogeno in linfociti umani. 173
Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line. 172
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease 170
Red chicory (Cichorium intybus L. cultivar) as a potential source of antioxidant anthocyanins for intestinal health 169
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease 168
Design, synthesis, and biological evaluation of new thalidomide–donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation 165
Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's Disease 164
Inhibition of Acetylcholinesterase, Beta-Amyloid Aggregation, and NMDA Receptors in Alzheimer's Disease: A Promising Direction for the Multi-target-Directed Ligands Gold Rush 163
Novel Class of Quinone-Bearing Polyamines as Multi-Target-Directed Ligands To Combat Alzheimer's Disease 161
Cyanidin 3-O-glucopyranoside protects and rescues SH-SY5Y cells against amyloid-beta peptide-induced toxicity. 160
Lipocrine, a multipotent drug for the investigation of Alzheimer's disease 159
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease. 157
Design, synthesis, and biological evaluation of substituted 2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamine related compounds as fructose-1,6-bisphosphatase inhibitors 155
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate. 155
Protective effects of chrysin against the neurotoxicity induced by aluminium: In vitro and in vivo studies 155
Protective effects of sulforaphane against oxidative stress-induced apoptosis in human neuronal cells 152
One-molecule-multiple-target strategy: a novel multifunctional molecule designed to block EGF-r and to exert pro-apoptotic effects 151
From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold 151
Neuroprotective effects of sulforaphane in an in vitro model of Parkinson’s disease 151
Neuroprotection by Drugs, Nutraceuticals and Physical Activity 150
Effetti antiapoptotici e antiossidanti della cianidina-3-O-beta-glucopiranoside e del suo aglicone in una linea neuronale umana. 150
Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers. 149
Design, Synthesis and Biological Evaluation of Novel Triazole N-acylhydrazone Hybrids for Alzheimer's Disease 149
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects 147
Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects 146
A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models 144
Qualità e sicurezza degli alimenti da agricoltura biologica 144
null 141
Discovery and evaluation of enantiopure 9H-pyrimido[4,5‐b]indoles as nanomolar GSK‐3β inhibitors with improved metabolic stability 141
Isothiocyanates as potentials alzheimer's disease-modifying drugs. 140
Influence of Cultivation System on Bioactive Molecules Synthesis in Strawberries: Spin-off on Antioxidant and Antiproliferative Activity 139
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks 139
La cianidina 3-O-glucopiranoside protegge le cellule neuronali in coltura dalla tossicità indotta dal peptide beta-amiloide. 138
Urinary Markers and Chronic Effect of Physical Exercise 138
La guanosina inibisce l'apoptosi indotta dalla proteina beta amiloide mediante upregulation dell'attività del proteasoma in una linea neuronale umana. 135
Cyanidin 3-O-glucopyranoside protects Sh-SY5Y cells against amyloid-B-peptide-induced toxicity 134
Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblatoma cell line. 132
Sulforaphane counteracts oxidative stress induced apoptosis in human neuronal cells 130
Chalcone-based carbamates for Alzheimer's disease treatment 129
Optimization of the Extraction from Spent Coffee Grounds Using the Desirability Approach 129
Esculetin provides neuroprotection against mutant huntingtin-induced toxicity in huntington’s disease models 129
La malattia di Parkinson: uno studio integrato tra genotipo funzionale e fenotipo patologico per lo sviluppo di nuove strategie di neuroprotezione 126
Curcumin and Heme Oxygenase: Neuroprotection and Beyond 125
null 123
Involvement of the proteasome system activation in the anti-apoptotic activity of guanine-based purines. 122
Cruciferae vegetables: a source of phytochemicals for brain health. 119
null 118
Development of new extracts of crocus sativus l. By-product from two different italian regions as new potential active ingredient in cosmetic formulations 118
Fruit attributes, phenolic compounds, antioxidant and antiproliferative activity of strawberries (Fragaria ananassa, 'Favette') grown by biodynamic and conventional agriculture methods 113
Totale 18.250
Categoria #
all - tutte 54.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021363 0 0 0 0 0 0 0 0 0 0 0 363
2021/20221.937 120 64 114 154 159 136 44 166 117 248 349 266
2022/20231.964 193 245 78 255 172 152 123 118 314 45 186 83
2023/2024937 42 120 86 94 54 188 59 94 26 65 48 61
2024/20252.896 148 344 270 169 582 127 222 101 53 197 189 494
2025/20267.115 530 761 601 526 667 337 713 296 1.350 558 353 423
Totale 19.604